Covetrus, Inc. (CVET)
Stock Price Chart
Key Info
| Market Cap | 2.88B |
| Revenue (ttm) | 4.12B |
| Net Income (ttm) | -975.00M |
| Shares Out | 112.83M |
| EPS (ttm) | -8.78 |
| PE Ratio | n/a |
| Forward PE | 41.67 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 27, 2020 |
| Last Price | $25.54 |
| Previous Close | $25.81 |
| Change ($) | -0.27 |
| Change (%) | -1.05% |
| Day's Open | 25.90 |
| Day's Range | 25.43 - 26.04 |
| Day's Volume | 1,009,965 |
| 52-Week Range | 4.05 - 28.77 |
More Stats
| Market Cap | 2.88B |
| Enterprise Value | 3.59B |
| Earnings Date (est) | Mar 9, 2021 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 112.83M |
| Float | 87.13M |
| EPS (basic) | -8.73 |
| EPS (diluted) | -8.78 |
| FCF / Share | 1.03 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 3.99% |
| Payout Ratio | n/a |
| Shares Short | 7.74M |
| Short Ratio | 9.56 |
| Short % of Float | 8.88% |
| Beta | n/a |
| PE Ratio | n/a |
| Forward PE | 41.67 |
| P/FCF Ratio | 25.06 |
| PS Ratio | 0.70 |
| PB Ratio | 2.69 |
| Revenue | 4.12B |
| Operating Income | -1.01B |
| Net Income | -975.00M |
| Free Cash Flow | 115.00M |
| Net Cash | -712.00M |
| Net Cash / Share | -6.31 |
| Gross Margin | 18.19% |
| Operating Margin | -24.46% |
| Profit Margin | -23.70% |
| FCF Margin | 2.79% |
| ROA | -1.02% |
| ROE | -51.62% |
| ROIC | -48.90% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Revenue | 3,976 | 3,778 | 3,580 | 3,353 | 2,978 |
| Revenue Growth | 5.24% | 5.53% | 6.76% | 12.59% | - |
| Gross Profit | 749 | 684 | 652 | 620 | 530 |
| Operating Income | -997 | 137 | 135 | 124 | 104 |
| Net Income | -1,019 | 101 | 64.00 | 70.30 | 60.32 |
| Shares Outstanding | 107 | 71.00 | 71.00 | 71.45 | - |
| Earnings Per Share | -9.50 | 1.40 | 0.89 | 0.98 | - |
| EPS Growth | - | 57.3% | -9.18% | - | - |
| Operating Cash Flow | 103 | 158 | 108 | 105 | 96.12 |
| Capital Expenditures | -39.00 | -21.00 | -20.00 | -12.14 | -9.00 |
| Free Cash Flow | 64.00 | 137 | 88.00 | 92.66 | 87.12 |
| Cash & Equivalents | 130 | 23.00 | 16.66 | 19.71 | - |
| Total Debt | 1,187 | 25.00 | 26.73 | 26.93 | - |
| Net Cash / Debt | -1,057 | -2.00 | -10.08 | -7.22 | - |
| Assets | 3,361 | 2,233 | 2,217 | 1,945 | - |
| Liabilities | 2,095 | 647 | 593 | 544 | - |
| Book Value | 1,256 | 1,494 | 1,257 | 1,079 | - |
Company Profile
Company Details
| Full Name | Covetrus, Inc. |
| Country | United States |
| Employees | 5,100 |
| CEO | Benjamin C. Wolin |
Stock Information
| Ticker Symbol | CVET |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Unique Identifier | NASDAQ: CVET |
Description
Covetrus, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins and supplements to wholesale and retail customers. The company also offers value-added practice solutions that include financial services, equipment repair, inventory management, and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as e-commerce, shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company, formerly known as HS Spinco, Inc., was incorporated in 2018 and is headquartered in Portland, Maine.